Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up-Reference-Cited by-同舟云学术

Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up

Published:2017-12 Issue:12 Volume:31 Page:e13133
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Peled Yael¹²,Lavee Jacob¹²^ORCID,Raichlin Eugenia³,Katz Moshe¹²,Arad Michael¹²,Kassif Yigal¹²,Peled Amir⁴,Asher Elad¹²,Elian Dan¹²,Har-Zahav Yedael¹,Shlomo Nir⁵,Freimark Dov¹²,Goldenberg Ilan¹²⁵,Klempfner Robert¹²

Affiliation:

1. The Leviev Heart Center; Sheba Medical Center; Tel Hashomer Israel

2. Sackler School of Medicine; Tel Aviv University; Tel Aviv Israel

3. Cardiology Department; Loyola University Medical Center; Maywood IL USA

4. Clalit Health Services; Central Region; Tel Aviv Israel

5. Israeli Association for Cardiovascular Trials; Sheba Medical Center; Israel

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.13133/fullpdf

Reference40 articles.

1. The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation report-2016; focus theme: primary diagnostic indications for transplant;Lund;J Heart Lung Transplant,2016

2. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients;Eisen;N Engl J Med,2003

3. Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis;Vigano;J Heart Lung Transplant,2007

4. The impact of proliferation signal inhibitors on the healthcare burden of major adverse cardiac events following heart transplantation;Eisen;Transplantation,2006

5. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial;Keogh;Circulation,2004

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients;Transplantation;2024-07-18

2. Cardiac allograft vasculopathy: current review;Russian Journal of Transplantology and Artificial Organs;2024-03-19

3. Acetylsalicylic acid use and development of cardiac allograft vasculopathy: A national prospective study using highly automated 3‐D optical coherence tomography analysis;Clinical Transplantation;2024-03

4. Cardiac Allograft Vasculopathy;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2023-08-29